Granahan Investment Management, LLC Fulgent Genetics, Inc. Transaction History

Granahan Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$3.12 - $4.09 $709,828 - $930,511	-227,509 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$3.29 - $5.12 $908 - $1,413	276 Added 0.12%	227,509 $894,000
Q2 2018 Aug 15, 2018	BUY	$3.57 - $4.85 $122,197 - $166,010	34,229 Added 17.73%	227,233 $941,000
Q1 2018 May 14, 2018	SELL	$3.67 - $5.19 $262,834 - $371,692	-71,617 Reduced 27.06%	193,004 $772,000
Q4 2017 Feb 12, 2018	BUY	$3.01 - $4.9 $79,430 - $129,306	26,389 Added 11.08%	264,621 $1.16 Million
Q3 2017 Nov 14, 2017	BUY	$4.57 - $6.39 $1.09 Million - $1.52 Million	238,232	238,232 $1.14 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.